What is Biltmore Technologies?
Biltmore Technologies specializes in providing advanced Pharma Analytics solutions tailored for the Life Sciences industry. Their core offering, My Vital Signs Rx, is a cloud-based Platform-as-a-Service designed to deliver comprehensive data management, business intelligence, and reporting capabilities. This platform empowers life science companies to make more informed decisions by offering deep insights into their operations. Beyond their flagship product, Biltmore Technologies also provides bespoke consulting services and develops white label applications to support client-specific sales and marketing initiatives, aiming to streamline operations and enhance market presence.
How much funding has Biltmore Technologies raised?
Biltmore Technologies has raised a total of $268K across 2 funding rounds:
Debt
$150K
Debt
$118K
Debt (2020): $150K with participation from PPP
Debt (2021): $118K led by PPP
What's next for Biltmore Technologies?
With the recent influx of capital from a major strategic investment, Biltmore Technologies is poised for accelerated growth and expansion. The company's focus on enhancing decision-making through data analytics in the complex Life Sciences landscape, coupled with its late-stage funding context, suggests a strategic push towards scaling operations, further developing its platform, and potentially broadening its market reach. This investment will likely fuel advancements in their cloud-based solutions and consulting services, reinforcing their position as a critical technology partner for pharmaceutical and biotech firms.
See full Biltmore Technologies company page
